p53 Regulation of Metabolic Pathways

被引:144
作者
Gottlieb, Eyal [1 ]
Vousden, Karen H. [1 ]
机构
[1] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland
关键词
WILD-TYPE P53; CELL METABOLISM; CANCER-CELLS; TUMOR; PROTEIN; RESTORATION; GLYCOLYSIS; METFORMIN; GENE; CHEMOTHERAPY;
D O I
10.1101/cshperspect.a001040
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
During the course of tumorigenesis, cells acquire a number of alterations that contribute to the acquisition of the malignant phenotype, allowing them to survive and flourish in increasingly hostile environments. Cancer cells can be characterized by perturbations in the control of cell proliferation and growth, resistance to death, and alterations in their interactions with the microenvironment. Underpinning many of these changes are shifts in metabolism that allow cancer cells to use alternative pathways for energy production and building the macromolecules necessary for growth, as well as regulating the generation of signaling molecules such as reactive oxygen species (ROS). In the past few years, it became clear that p53, the most studied, if not most important, tumor suppressor protein, can also directly control metabolic traits of cells.
引用
收藏
页数:11
相关论文
共 61 条
[1]
Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[2]
TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[3]
TP53 status and response to chemotherapy in breast cancer [J].
Bertheau, Philippe ;
Espie, Marc ;
Turpin, Elisabeth ;
Lehmann, Jacqueline ;
Plassa, Louis-Francois ;
Varna, Mariana ;
Janin, Anne ;
de The, Hugues .
PATHOBIOLOGY, 2008, 75 (02) :132-139
[4]
HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses [J].
Bertout, Jessica A. ;
Majmundar, Amar J. ;
Gordan, John D. ;
Lam, Jennifer C. ;
Ditsworth, Dara ;
Keith, Brian ;
Brown, Eric J. ;
Nathanson, Katherine L. ;
Simon, M. Celeste .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (34) :14391-14396
[5]
p53 inhibits hypoxia-inducible factor-stimulated transcription [J].
Blagosklonny, MV ;
An, WG ;
Romanova, LY ;
Trepel, J ;
Fojo, T ;
Neckers, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :11995-11998
[6]
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion [J].
Bourdon, Alice ;
Minai, Limor ;
Serre, Valerie ;
Jais, Jean-Philippe ;
Sarzi, Emmanuelle ;
Aubert, Sophie ;
Chretien, Dominique ;
de Lonlay, Pascale ;
Paquis-Flucklinger, Veronique ;
Arakawa, Hirofumi ;
Nakamura, Yusuke ;
Munnich, Arnold ;
Rotig, Agnes .
NATURE GENETICS, 2007, 39 (06) :776-780
[7]
Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD [J].
Budanov, AV ;
Sablina, AA ;
Feinstein, E ;
Koonin, EV ;
Chumakov, PM .
SCIENCE, 2004, 304 (5670) :596-600
[8]
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth [J].
Buzzai, Monica ;
Jones, Russell G. ;
Amaravadi, Ravi K. ;
Lum, Julian J. ;
DeBerardinis, Ralph J. ;
Zhao, Fangping ;
Viollet, Benoit ;
Thompson, Craig B. .
CANCER RESEARCH, 2007, 67 (14) :6745-6752
[9]
Tumor Protein 53-Induced Nucear Protein 1 Is a Major Mediator of p53 Antioxidant Function [J].
Cano, Carla E. ;
Gommeaux, Julien ;
Pietri, Sylvia ;
Culcasi, Marcel ;
Garcia, Stephane ;
Seux, Mylene ;
Barelier, Sarah ;
Vasseur, Sophie ;
Spoto, Rose P. ;
Pebusque, Marie-Josephe ;
Dusetti, Nelson J. ;
Iovanna, Juan L. ;
Carrier, Alice .
CANCER RESEARCH, 2009, 69 (01) :219-226
[10]
Direct interactions between HIF-1α and Mdm2 modulate p53 function [J].
Chen, DL ;
Li, MY ;
Luo, JY ;
Gu, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13595-13598